Pubrica Meta-Analysis solutions for Product Development and Refinement Immunotherapy has emerged as an innovative approach to cancer treatment, but its effectiveness varies widely among patients. Tumor mutation burden (TMB) has been proposed as a potential predictive biomarker for immunotherapy response. This study aims to conduct a meta-analysis and bioinformatics assessment of TMB’s role in predicting immunotherapy effects across various cancer types. Through a comprehensive review of existing literature and the integration of large-scale genomic datasets, we seek to elucidate the relationship between TMB and immunotherapy outcomes. Read more @ https://pubrica.com/academy/systematic-review/meta-analysis-and-bioinformatics-assessment-of-tumour-mutation/ Visit us for your completing your professional meta analysis writing @ https://pubrica.com/services/research-services/meta-analysis/